W, Y., Z, C., H, D., Q, N., Y, L., Y, L., . . . L, H. (2026). The bleeding risk of low-molecular-weight heparin bridging therapy in patients receiving preoperative oral antithrombotic drugs during spinal fusion surgery. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. https://doi.org/10.1007/s00586-026-10207-9
Chicago Style (17th ed.) CitationW, Yan, et al. "The Bleeding Risk of Low-molecular-weight Heparin Bridging Therapy in Patients Receiving Preoperative Oral Antithrombotic Drugs During Spinal Fusion Surgery." European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2026. https://doi.org/10.1007/s00586-026-10207-9.
MLA (9th ed.) CitationW, Yan, et al. "The Bleeding Risk of Low-molecular-weight Heparin Bridging Therapy in Patients Receiving Preoperative Oral Antithrombotic Drugs During Spinal Fusion Surgery." European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026, https://doi.org/10.1007/s00586-026-10207-9.
